Early results from the Phase I/II NXTAGE trial show that NXT007 may achieve hemostatic normalization in patients with ...

Low dose of emicizumab could be as effective as standard dose against Haemophilia A, according to a study led by the Indian ...

In Hooghly district, haemophilia injections have not been available at either Chinsurah Imambara Hospital or Arambagh Medical ...

Novo Nordisk NVO announced new data from the phase III FRONTIER clinical program, comprising five separate studies evaluating ...

The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...

Mim8 (denecimig) prophylaxis was well-tolerated in FRONTIER5 phase 3 switch trial in people with haemophilia A ·         New FRONTIER5 data shows direct switch to Mim8 prophylaxis treatment from ...

Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...

A cost-effective point-of-care test kit has been developed in India for early diagnosis of haemophilia A and Von Willebrand Disease, offering a more accessible alternative to expensive lab tests. This ...

The Indian Council of Medical Research's National Institute of Immunohaematology (ICMR's NIIH) has developed a cost-effective ...

A patient at Guy’s and St Thomas’ recently received the first treatment in the UK of a new, potentially life-changing ...

A single infusion of adeno-associated virus (AAV)-mediated gene therapy led to sustained clinical benefit and no late-onset ...

Factor IX, and FEIBA (Anti-Inhibitor Coagulant Complex), which are critical for preventing fatal bleeds in patients with the ...